Production Of Proteins In Glutamine-Free Cell Culture Media - EP2464725

The patent EP2464725 was granted to F Hoffmann LA Roche on Jan 15, 2025. The application was originally filed on Aug 6, 2010 under application number EP10745064A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2464725

F HOFFMANN LA ROCHE
Application Number
EP10745064A
Filing Date
Aug 6, 2010
Status
Patent Maintained As Amended
Dec 13, 2024
Grant Date
Jan 15, 2025
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

HOFFMANN EITLEDec 23, 2020HOFFMANN EITLEADMISSIBLE
POHLMANDec 23, 2020-ADMISSIBLE

Patent Citations (185) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO1998US13410
DESCRIPTIONEP0003089
DESCRIPTIONEP0117058
DESCRIPTIONEP0117060
DESCRIPTIONEP0117159
DESCRIPTIONEP0307247
DESCRIPTIONEP0330191
DESCRIPTIONEP0332865
DESCRIPTIONEP0404097
DESCRIPTIONEP0420937
DESCRIPTIONUS2002004587
DESCRIPTIONUS2002006404
DESCRIPTIONUS2002009444
DESCRIPTIONUS2002012665
DESCRIPTIONUS2002041847
DESCRIPTIONUS2002058029
DESCRIPTIONUS2002128488
DESCRIPTIONUS2002197255
DESCRIPTIONUS2002197256
DESCRIPTIONUS2003021781
DESCRIPTIONUS2003026801
DESCRIPTIONUS2003068664
DESCRIPTIONUS2003082172
DESCRIPTIONUS2003095963
DESCRIPTIONUS2003103971
DESCRIPTIONUS2003147885
DESCRIPTIONUS2003157108
DESCRIPTIONUS2003175884
DESCRIPTIONUS2003185796
DESCRIPTIONUS2003219433
DESCRIPTIONUS2003219818
DESCRIPTIONUS2004093621
DESCRIPTIONUS2004110704
DESCRIPTIONUS2004132140
DESCRIPTIONUS2004186051
DESCRIPTIONUS2005070689
DESCRIPTIONUS2006246004
DESCRIPTIONUS4399216
DESCRIPTIONUS4515893
DESCRIPTIONUS4560655
DESCRIPTIONUS4657866
DESCRIPTIONUS4676980
DESCRIPTIONUS4766075
DESCRIPTIONUS4767704
DESCRIPTIONUS4816567
DESCRIPTIONUS4853330
DESCRIPTIONUS4861579
DESCRIPTIONUS4927762
DESCRIPTIONUS5091178
DESCRIPTIONUS5091313
DESCRIPTIONUS5122469
DESCRIPTIONUS5185259
DESCRIPTIONUS5500362
DESCRIPTIONUS5545806
DESCRIPTIONUS5545807
DESCRIPTIONUS5569825
DESCRIPTIONUS5595721
DESCRIPTIONUS5622700
DESCRIPTIONUS5625126
DESCRIPTIONUS5633425
DESCRIPTIONUS5641870
DESCRIPTIONUS5661016
DESCRIPTIONUS5672347
DESCRIPTIONUS5677180
DESCRIPTIONUS5693762
DESCRIPTIONUS5714338
DESCRIPTIONUS5721108
DESCRIPTIONUS5725856
DESCRIPTIONUS5736137
DESCRIPTIONUS5750373
DESCRIPTIONUS5776456
DESCRIPTIONUS5783186
DESCRIPTIONUS5821333
DESCRIPTIONUS5821337
DESCRIPTIONUS5843398
DESCRIPTIONUS5843439
DESCRIPTIONUS5849898
DESCRIPTIONUS6015542
DESCRIPTIONUS6037454
DESCRIPTIONUS6075181
DESCRIPTIONUS6090365
DESCRIPTIONUS6120767
DESCRIPTIONUS6150584
DESCRIPTIONUS6171586
DESCRIPTIONUS6194551
DESCRIPTIONUS6224866
DESCRIPTIONUS6242195
DESCRIPTIONUS6287537
DESCRIPTIONUS6368596
DESCRIPTIONUS6399061
DESCRIPTIONUS6410391
DESCRIPTIONUS6455043
DESCRIPTIONUS6528624
DESCRIPTIONUS6538124
DESCRIPTIONUS6602684
DESCRIPTIONUS6610516
DESCRIPTIONUS6982321
DESCRIPTIONUS7060269
DESCRIPTIONUS7087409
DESCRIPTIONUS7169901
DESCRIPTIONUS7297334
DESCRIPTIONWO0009160
DESCRIPTIONWO0020864
DESCRIPTIONWO0027428
DESCRIPTIONWO0027433
DESCRIPTIONWO0042072
DESCRIPTIONWO0044788
DESCRIPTIONWO0067795
DESCRIPTIONWO0067796
DESCRIPTIONWO0074718
DESCRIPTIONWO0075348
DESCRIPTIONWO0076542
DESCRIPTIONWO0103734
DESCRIPTIONWO0110460
DESCRIPTIONWO0110461
DESCRIPTIONWO0110462
DESCRIPTIONWO0113945
DESCRIPTIONWO0140309
DESCRIPTIONWO0172333
DESCRIPTIONWO0174388
DESCRIPTIONWO0177342
DESCRIPTIONWO0180884
DESCRIPTIONWO0197858
DESCRIPTIONWO0204021
DESCRIPTIONWO02060955
DESCRIPTIONWO02079255
DESCRIPTIONWO02096948
DESCRIPTIONWO02102312
DESCRIPTIONWO0234790
DESCRIPTIONWO03002607
DESCRIPTIONWO03049694
DESCRIPTIONWO03061694
DESCRIPTIONWO03068821
DESCRIPTIONWO2004092219
DESCRIPTIONWO2006083971
DESCRIPTIONWO8700195
DESCRIPTIONWO8905859
DESCRIPTIONWO9003430
DESCRIPTIONWO9100358
DESCRIPTIONWO9100360
DESCRIPTIONWO9110741
DESCRIPTIONWO9304173
DESCRIPTIONWO9308829
DESCRIPTIONWO9311161
DESCRIPTIONWO9316185
DESCRIPTIONWO9400136
DESCRIPTIONWO9503770
DESCRIPTIONWO9519181
DESCRIPTIONWO9523865
DESCRIPTIONWO9627011
DESCRIPTIONWO9630046
DESCRIPTIONWO9633735
DESCRIPTIONWO9634096
DESCRIPTIONWO9640210
DESCRIPTIONWO9725428
DESCRIPTIONWO9726912
DESCRIPTIONWO9806248
DESCRIPTIONWO9823761
DESCRIPTIONWO9824893
DESCRIPTIONWO9845331
DESCRIPTIONWO9851793
DESCRIPTIONWO9856418
DESCRIPTIONWO9858964
DESCRIPTIONWO9922764
DESCRIPTIONWO9951642
EXAMINATIONWO2005083058
INTERNATIONAL-SEARCH-REPORTGB2237288
OPPOSITIONUS2008254513
OPPOSITIONUS6037454
OPPOSITIONUS6884879
OPPOSITIONUS7381560
OPPOSITIONWO0100245
OPPOSITIONWO02101019
OPPOSITIONWO03014294
OPPOSITIONWO2005065348
OPPOSITIONWO20050830581
OPPOSITIONWO2005083058
OPPOSITIONWO2006026408
OPPOSITIONWO2006026445
OPPOSITIONWO2006026447
OPPOSITIONWO2006083971
OPPOSITIONWO2007036291
OPPOSITIONWO2008033517
OPPOSITIONWO2009047007
OTHERWO2005083058

Non-Patent Literature (NPL) Citations (15) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
OPPOSITION- Anonymous, "Asparagine Wikipedia", Wikipedia, (20090613), XP055777936
OPPOSITION- Anonymous, "Classical Cell Culture Media", R&D Systems Cell Culture Media, (20230101), R&D Systems Cell Culture Media, URL: https://www.rndsystems.com/products/cell-culture-media , XP093170668
OPPOSITION- Anonymous, "Eagle's minimal essential medium", Wikipedia, the free encyclopedia, (20190517), Wikipedia, the free encyclopedia, URL: https://en.wikipedia.org/wiki/Eagle%27s_minimal_essential_medium, (20191014), XP055631669
OPPOSITION- Bachmann Fedor, Et Al, "Tissue Plasminogen Activator: Chemical and Physiological Aspects", Semin Thromb Hemost, (19840101), vol. 10, no. 1, XP055777932
OPPOSITION- DRYING, C. et al., "Observations on the influence of glutamine, asparagine and peptone on growth and t-PA production of Chinese hamster ovary (CHO) cells", Cytotech, (19940000), vol. 16, pages 37 - 42, XP055458559
OPPOSITION- Hansen Henrik A, Emborg Claus, "NOTES Influence of Ammonium on Growth, Metabolism, and Productivity of a Continuous Suspension Chinese Hamster Ovary Cell Culture", Biotechnol. hog, (19940101), pages 121 - 124, Biotechnol. hog, (20210222), XP055778173
OPPOSITION- OZTURK et al., Cell culture technology for pharmaceutical and cell based therapies, (20060000), pages 1 - 80
OPPOSITION- Ozturk Sadettin S, Et Al, "Cell Metabolism", Cell Culture Technology for Pharmaceutical and Cell -Based Therapies, Taylor & Francis, (20050101), XP055777937
OPPOSITION- Younes Anas, Et Al, "tumor necrosis factor family of ligands and receptors in cancer therapy", The Oncogenomics Handbook, Humana Press, (20050101), XP055777941
OPPOSITION- WANG et al., "Antibody Structure, Instability, and Formulation", J. Pharm. Sci., (20070000), vol. 96, no. 1, doi:10.1002/jps.20727, pages 1 - 26, XP009084505
OPPOSITION- Sanfeliu Anna, Stephanopoulos Gregory, "Effect of glutamine limitation on the death of attached Chinese hamster ovary cells", BIOTECHNOLOGY AND BIOENGINEERING, Wiley, US, US, (19990705), vol. 64, no. 1, doi:10.1002/(SICI)1097-0290(19990705)64:1<46::AID-BIT5>3.0.CO;2-9, ISSN 0006-3592, pages 46 - 53, XP055777928
OPPOSITION- ZHANG et al., "Metabolic characteristics of recombinant Chinese hamster ovary cells expressing glutamine synthetase in presence and absence of glutamine", Cytotechnology, (20060000), vol. 51, pages 21 - 28, XP002592402
OPPOSITION- KUMAR, N. et al., "Proliferation control strategies to improve productivity and survival during CHO based production culture", Cytotechnol, (20070000), vol. 53, doi:10.1007/s10616-007-9047-6, pages 33 - 46, XP019499816
OPPOSITION- KURANO et al., "Growth behavior of Chinese hamster ovary cells in a compact loop bioreactor. 2. Effects of medium components and waste products", Journal of Biotechnology, (19900000), vol. 15, pages 113 - 128, XP023704790
OPPOSITION- BARN ES, L.M et al., "Advances in animal cell recombinant protein production: GS-NS0 expression system", Cytotechnol, (20000000), vol. 32, doi:10.1023/A:1008170710003, pages 109 - 123, XP002301322

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents